• Home
  • About Us
  • Team
  • Our Science
  • Our Pipeline
  • Clinical Trials
  • Contact
  • Careers
  • Contact
  • About Us
    • Team
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Investors
      • Partners
  • Our Science
    • Novel Approach
    • Targeting RNA
    • Our Platform
    • RSwitch
  • Our Pipeline
    • Pipeline
    • Oncology
    • CNS Disorders
    • Clinical Trials
  • Why Rgenta
  • News
    • Press Releases
    • News
    • Events and Presentations
Rgenta Logo

Rgenta's novel approach enables the development of RNA-targeting medicines to treat previously incurable diseases.

Rgenta's novel approach enables the development of RNA-targeting medicines to treat previously incurable diseases.

Website design by

Boston Web Partners

VISIT

300 TradeCenter
Suite 6600
Woburn, MA 01801
info@rgentatx.com

CONTACT

info@rgentatx.com
© 2026 

All Rights Reserved | Rgenta Therapeutics

  • Team
  • Why Rgenta
  • Our Science
  • Our Pipeline
  • Privacy Policy
Share by: